Glucose concentrations of less than 3.0 mmol/l (54 mg/dl) should be reported in clinical trials: a joint position statement of the American Diabetes Association and the Europian Association for the Study of Diabetes

Stephanie A. Amiel; Pablo Aschner; Belinda Childs R N; Philip E. Cryer; Bastiaan E. de Galan; Simon R. Heller; Brian M. Frier; Linda Gonder-Frederick; Timothy Jones; Timothy Jones; Kamlesh Khunti; Lawrence A. Leiter; Rory J. McCrimmon; Yingying Luo; Elizabeth R Seaquist; Robert Vigersky; Sophia Zoungas; The International Hypoglycaemia Study Group

doi:10.1007/s00125-016-4146-6

Glucose concentrations of less than 3.0 mmol/l (54 mg/dl) should be reported in clinical trials: a joint position statement of the American Diabetes Association and the Europian Association for the Study of Diabetes

Stephanie A. Amiel
, Pablo Aschner
, Belinda Childs R N
, Philip E. Cryer
, Bastiaan E. de Galan
, Simon R. Heller
, Brian M. Frier
, Linda Gonder-Frederick
, Timothy Jones
, Timothy Jones
, Kamlesh Khunti
, Lawrence A. Leiter
, Rory J. McCrimmon
, Yingying Luo
, Elizabeth R Seaquist
, Robert Vigersky
, Sophia Zoungas
, The International Hypoglycaemia Study Group

Medicine - Endocrine and Diabetes Division

Research output: Contribution to journal › Article › peer-review

102 Scopus citations

Original language	English (US)
Pages (from-to)	3-6
Number of pages	4
Journal	Diabetologia
Volume	60
Issue number	1
DOIs	https://doi.org/10.1007/s00125-016-4146-6
State	Published - Jan 1 2017

Bibliographical note

Funding Information:
The International Hypoglycaemia Study Group (IHSG) is supported through an unrestricted educational grant from Novo Nordisk awarded to Six Degrees Academy (SDA) of Toronto, ON, Canada. Along with the IHSG chair, SDA has been solely responsible for membership recruitment/selection and content/outcomes for the meetings. The rationale for the formation of IHSG is that hypoglycaemia is an under-recognised problem that deserves increased awareness and focus across the healthcare community. The group’s ultimate goal is to improve the lives of patients with diabetes.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Publisher link

10.1007/s00125-016-4146-6

Find It

Find It at U of M Libraries

Cite this

Amiel, S. A., Aschner, P., Childs R N, B., Cryer, P. E., de Galan, B. E., Heller, S. R., Frier, B. M., Gonder-Frederick, L., Jones, T., Jones, T., Khunti, K., Leiter, L. A., McCrimmon, R. J., Luo, Y., Seaquist, E. R., Vigersky, R., Zoungas, S., & The International Hypoglycaemia Study Group (2017). Glucose concentrations of less than 3.0 mmol/l (54 mg/dl) should be reported in clinical trials: a joint position statement of the American Diabetes Association and the Europian Association for the Study of Diabetes. Diabetologia, 60(1), 3-6. https://doi.org/10.1007/s00125-016-4146-6

Glucose concentrations of less than 3.0 mmol/l (54 mg/dl) should be reported in clinical trials: a joint position statement of the American Diabetes Association and the Europian Association for the Study of Diabetes. / Amiel, Stephanie A.; Aschner, Pablo; Childs R N, Belinda et al.
In: Diabetologia, Vol. 60, No. 1, 01.01.2017, p. 3-6.

Research output: Contribution to journal › Article › peer-review

Amiel, SA, Aschner, P, Childs R N, B, Cryer, PE, de Galan, BE, Heller, SR, Frier, BM, Gonder-Frederick, L, Jones, T, Jones, T, Khunti, K, Leiter, LA, McCrimmon, RJ, Luo, Y, Seaquist, ER, Vigersky, R, Zoungas, S & The International Hypoglycaemia Study Group 2017, 'Glucose concentrations of less than 3.0 mmol/l (54 mg/dl) should be reported in clinical trials: a joint position statement of the American Diabetes Association and the Europian Association for the Study of Diabetes', Diabetologia, vol. 60, no. 1, pp. 3-6. https://doi.org/10.1007/s00125-016-4146-6

@article{cb1976e84bc047e095597cdbe10e5e1d,

title = "Glucose concentrations of less than 3.0 mmol/l (54 mg/dl) should be reported in clinical trials: a joint position statement of the American Diabetes Association and the Europian Association for the Study of Diabetes",

author = "Amiel, \{Stephanie A.\} and Pablo Aschner and \{Childs R N\}, Belinda and Cryer, \{Philip E.\} and \{de Galan\}, \{Bastiaan E.\} and Heller, \{Simon R.\} and Frier, \{Brian M.\} and Linda Gonder-Frederick and Timothy Jones and Timothy Jones and Kamlesh Khunti and Leiter, \{Lawrence A.\} and McCrimmon, \{Rory J.\} and Yingying Luo and Seaquist, \{Elizabeth R\} and Robert Vigersky and Sophia Zoungas and \{The International Hypoglycaemia Study Group\}",

note = "Funding Information: The International Hypoglycaemia Study Group (IHSG) is supported through an unrestricted educational grant from Novo Nordisk awarded to Six Degrees Academy (SDA) of Toronto, ON, Canada. Along with the IHSG chair, SDA has been solely responsible for membership recruitment/selection and content/outcomes for the meetings. The rationale for the formation of IHSG is that hypoglycaemia is an under-recognised problem that deserves increased awareness and focus across the healthcare community. The group{\textquoteright}s ultimate goal is to improve the lives of patients with diabetes. ",

year = "2017",

month = jan,

day = "1",

doi = "10.1007/s00125-016-4146-6",

language = "English (US)",

volume = "60",

pages = "3--6",

journal = "Diabetologia",

issn = "0012-186X",

publisher = "Springer Science and Business Media Deutschland GmbH",

number = "1",

}

TY - JOUR

T1 - Glucose concentrations of less than 3.0 mmol/l (54 mg/dl) should be reported in clinical trials

T2 - a joint position statement of the American Diabetes Association and the Europian Association for the Study of Diabetes

AU - Amiel, Stephanie A.

AU - Aschner, Pablo

AU - Childs R N, Belinda

AU - Cryer, Philip E.

AU - de Galan, Bastiaan E.

AU - Heller, Simon R.

AU - Frier, Brian M.

AU - Gonder-Frederick, Linda

AU - Jones, Timothy

AU - Khunti, Kamlesh

AU - Leiter, Lawrence A.

AU - McCrimmon, Rory J.

AU - Luo, Yingying

AU - Seaquist, Elizabeth R

AU - Vigersky, Robert

AU - Zoungas, Sophia

AU - The International Hypoglycaemia Study Group

N1 - Funding Information: The International Hypoglycaemia Study Group (IHSG) is supported through an unrestricted educational grant from Novo Nordisk awarded to Six Degrees Academy (SDA) of Toronto, ON, Canada. Along with the IHSG chair, SDA has been solely responsible for membership recruitment/selection and content/outcomes for the meetings. The rationale for the formation of IHSG is that hypoglycaemia is an under-recognised problem that deserves increased awareness and focus across the healthcare community. The group’s ultimate goal is to improve the lives of patients with diabetes.

PY - 2017/1/1

Y1 - 2017/1/1

UR - https://www.scopus.com/pages/publications/84996598780

UR - https://www.scopus.com/pages/publications/84996598780#tab=citedBy

U2 - 10.1007/s00125-016-4146-6

DO - 10.1007/s00125-016-4146-6

M3 - Article

C2 - 27872948

AN - SCOPUS:84996598780

SN - 0012-186X

VL - 60

SP - 3

EP - 6

JO - Diabetologia

JF - Diabetologia

IS - 1